Literature DB >> 29179896

Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.

Erika G Odisio1, Edith M Marom2, Girish S Shroff1, Carol C Wu1, Ana Paula A Benveniste3, Mylene T Truong1, Marcelo F Benveniste4.   

Abstract

Malignant pleural mesothelioma is the most common primary neoplasm of the pleura. Imaging evaluation is essential in diagnosis, staging, and assessment of treatment response in malignant pleural mesothelioma. Computed tomography is the most commonly used modality for tumor staging. Assessment of tumor extension and lymph node involvement is essential in imaging evaluation as locally advanced tumors are amenable to resection. Knowledge of the full imaging spectrum of this rare disease, differential diagnosis, staging classification, and the current guidelines for diagnostic evaluation and follow-up are essential in accurate interpretation to optimize patient management.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29179896     DOI: 10.1053/j.sult.2017.07.006

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  3 in total

1.  Staging in the era of international databases: documented improvements with remaining challenges.

Authors:  Robert B Cameron
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 2.  Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma.

Authors:  Stefano Burgio; Leila Noori; Antonella Marino Gammazza; Claudia Campanella; Mariantonia Logozzi; Stefano Fais; Fabio Bucchieri; Francesco Cappello; Celeste Caruso Bavisotto
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

Review 3.  The Use of Chest Magnetic Resonance Imaging in Malignant Pleural Mesothelioma Diagnosis.

Authors:  Federica Volpi; Caterina A D'Amore; Leonardo Colligiani; Alessio Milazzo; Silvia Cavaliere; Annalisa De Liperi; Emanuele Neri; Chiara Romei
Journal:  Diagnostics (Basel)       Date:  2022-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.